421 related articles for article (PubMed ID: 19245828)
1. Epigenetics, oxidative stress, and Alzheimer disease.
Zawia NH; Lahiri DK; Cardozo-Pelaez F
Free Radic Biol Med; 2009 May; 46(9):1241-9. PubMed ID: 19245828
[TBL] [Abstract][Full Text] [Related]
2. The environment, epigenetics and amyloidogenesis.
Wu J; Basha MR; Zawia NH
J Mol Neurosci; 2008; 34(1):1-7. PubMed ID: 18157652
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's disease (AD)-like pathology in aged monkeys after infantile exposure to environmental metal lead (Pb): evidence for a developmental origin and environmental link for AD.
Wu J; Basha MR; Brock B; Cox DP; Cardozo-Pelaez F; McPherson CA; Harry J; Rice DC; Maloney B; Chen D; Lahiri DK; Zawia NH
J Neurosci; 2008 Jan; 28(1):3-9. PubMed ID: 18171917
[TBL] [Abstract][Full Text] [Related]
4. Oxidative damage in brain from human mutant APP/PS-1 double knock-in mice as a function of age.
Abdul HM; Sultana R; St Clair DK; Markesbery WR; Butterfield DA
Free Radic Biol Med; 2008 Nov; 45(10):1420-5. PubMed ID: 18762245
[TBL] [Abstract][Full Text] [Related]
5. Environmental risk factors and the developmental basis for Alzheimer's disease.
Zawia NH; Basha MR
Rev Neurosci; 2005; 16(4):325-37. PubMed ID: 16519009
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer's disease biomarkers and epigenetic intermediates following exposure to Pb in vitro.
Bihaqi SW; Zawia NH
Curr Alzheimer Res; 2012 Jun; 9(5):555-62. PubMed ID: 22272629
[TBL] [Abstract][Full Text] [Related]
7. Exposure to As-, Cd-, and Pb-mixture induces Aβ, amyloidogenic APP processing and cognitive impairments via oxidative stress-dependent neuroinflammation in young rats.
Ashok A; Rai NK; Tripathi S; Bandyopadhyay S
Toxicol Sci; 2015 Jan; 143(1):64-80. PubMed ID: 25288670
[TBL] [Abstract][Full Text] [Related]
8. APP transgenic modeling of Alzheimer's disease: mechanisms of neurodegeneration and aberrant neurogenesis.
Crews L; Rockenstein E; Masliah E
Brain Struct Funct; 2010 Mar; 214(2-3):111-26. PubMed ID: 20091183
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic mechanisms underlying cognitive impairment and Alzheimer disease hallmarks in 5XFAD mice.
Griñán-Ferré C; Sarroca S; Ivanova A; Puigoriol-Illamola D; Aguado F; Camins A; Sanfeliu C; Pallàs M
Aging (Albany NY); 2016 Apr; 8(4):664-84. PubMed ID: 27013617
[TBL] [Abstract][Full Text] [Related]
10. Amyloid protein-mediated differential DNA methylation status regulates gene expression in Alzheimer's disease model cell line.
Sung HY; Choi EN; Ahn Jo S; Oh S; Ahn JH
Biochem Biophys Res Commun; 2011 Nov; 414(4):700-5. PubMed ID: 22001921
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic mechanisms of amyloid-β production in anisomycin-treated SH-SY5Y cells.
Guo X; Wu X; Ren L; Liu G; Li L
Neuroscience; 2011 Oct; 194():272-81. PubMed ID: 21843603
[TBL] [Abstract][Full Text] [Related]
12. Infant exposure to lead (Pb) and epigenetic modifications in the aging primate brain: implications for Alzheimer's disease.
Bihaqi SW; Huang H; Wu J; Zawia NH
J Alzheimers Dis; 2011; 27(4):819-33. PubMed ID: 21891863
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic Regulation of Amyloid-beta Metabolism in Alzheimer's Disease.
He C; Huang ZS; Yu CC; Wang HH; Zhou H; Kong LH
Curr Med Sci; 2020 Dec; 40(6):1022-1030. PubMed ID: 33428129
[TBL] [Abstract][Full Text] [Related]
14. Antisense directed at the Abeta region of APP decreases brain oxidative markers in aged senescence accelerated mice.
Poon HF; Joshi G; Sultana R; Farr SA; Banks WA; Morley JE; Calabrese V; Butterfield DA
Brain Res; 2004 Aug; 1018(1):86-96. PubMed ID: 15262209
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress induces DNA demethylation and histone acetylation in SH-SY5Y cells: potential epigenetic mechanisms in gene transcription in Aβ production.
Gu X; Sun J; Li S; Wu X; Li L
Neurobiol Aging; 2013 Apr; 34(4):1069-79. PubMed ID: 23141413
[TBL] [Abstract][Full Text] [Related]
17. Regulation of Alzheimer beta-amyloid precursor trafficking and metabolism.
Gandy S; Petanceska S
Biochim Biophys Acta; 2000 Jul; 1502(1):44-52. PubMed ID: 10899430
[TBL] [Abstract][Full Text] [Related]
18. Genomics of Alzheimer Disease: A Review.
Rosenberg RN; Lambracht-Washington D; Yu G; Xia W
JAMA Neurol; 2016 Jul; 73(7):867-74. PubMed ID: 27135718
[TBL] [Abstract][Full Text] [Related]
19. CART mitigates oxidative stress and DNA damage in memory deficits of APP/PS1 mice via upregulating β‑amyloid metabolism‑associated enzymes.
Jiang H; Niu F; Zheng Y; Xu Y
Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33604684
[TBL] [Abstract][Full Text] [Related]
20. Altered CpG methylation in sporadic Alzheimer's disease is associated with APP and MAPT dysregulation.
Iwata A; Nagata K; Hatsuta H; Takuma H; Bundo M; Iwamoto K; Tamaoka A; Murayama S; Saido T; Tsuji S
Hum Mol Genet; 2014 Feb; 23(3):648-56. PubMed ID: 24101602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
